rs12453262

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014336.5(AIPL1):​c.277-10A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.56 in 1,611,246 control chromosomes in the GnomAD database, including 256,149 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 21911 hom., cov: 34)
Exomes 𝑓: 0.56 ( 234238 hom. )

Consequence

AIPL1
NM_014336.5 intron

Scores

2
Splicing: ADA: 0.00001746
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: -0.0900

Publications

11 publications found
Variant links:
Genes affected
AIPL1 (HGNC:359): (aryl hydrocarbon receptor interacting protein like 1) Leber congenital amaurosis (LCA) is the most severe inherited retinopathy with the earliest age of onset and accounts for at least 5% of all inherited retinal diseases. Affected individuals are diagnosed at birth or in the first few months of life with nystagmus, severely impaired vision or blindness and an abnormal or flat electroretinogram. The photoreceptor/pineal-expressed gene, AIPL1, encoding aryl-hydrocarbon interacting protein-like 1, is located within the LCA4 candidate region. The encoded protein contains three tetratricopeptide motifs, consistent with chaperone or nuclear transport activity. Mutations in this gene may cause approximately 20% of recessive LCA. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
AIPL1 Gene-Disease associations (from GenCC):
  • AIPL1-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Leber congenital amaurosis 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Leber congenital amaurosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 17-6428516-T-G is Benign according to our data. Variant chr17-6428516-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 99796.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.601 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AIPL1NM_014336.5 linkc.277-10A>C intron_variant Intron 2 of 5 ENST00000381129.8 NP_055151.3 Q9NZN9-1F1T0B6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AIPL1ENST00000381129.8 linkc.277-10A>C intron_variant Intron 2 of 5 1 NM_014336.5 ENSP00000370521.3 Q9NZN9-1

Frequencies

GnomAD3 genomes
AF:
0.527
AC:
80055
AN:
151996
Hom.:
21901
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.383
Gnomad AMI
AF:
0.462
Gnomad AMR
AF:
0.611
Gnomad ASJ
AF:
0.716
Gnomad EAS
AF:
0.497
Gnomad SAS
AF:
0.516
Gnomad FIN
AF:
0.551
Gnomad MID
AF:
0.747
Gnomad NFE
AF:
0.583
Gnomad OTH
AF:
0.590
GnomAD2 exomes
AF:
0.566
AC:
141360
AN:
249608
AF XY:
0.567
show subpopulations
Gnomad AFR exome
AF:
0.377
Gnomad AMR exome
AF:
0.656
Gnomad ASJ exome
AF:
0.720
Gnomad EAS exome
AF:
0.504
Gnomad FIN exome
AF:
0.552
Gnomad NFE exome
AF:
0.577
Gnomad OTH exome
AF:
0.600
GnomAD4 exome
AF:
0.564
AC:
822435
AN:
1459132
Hom.:
234238
Cov.:
44
AF XY:
0.563
AC XY:
409098
AN XY:
726038
show subpopulations
African (AFR)
AF:
0.377
AC:
12583
AN:
33420
American (AMR)
AF:
0.649
AC:
29025
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.722
AC:
18846
AN:
26116
East Asian (EAS)
AF:
0.497
AC:
19736
AN:
39678
South Asian (SAS)
AF:
0.522
AC:
45004
AN:
86192
European-Finnish (FIN)
AF:
0.549
AC:
28999
AN:
52862
Middle Eastern (MID)
AF:
0.713
AC:
4113
AN:
5768
European-Non Finnish (NFE)
AF:
0.567
AC:
629567
AN:
1110088
Other (OTH)
AF:
0.573
AC:
34562
AN:
60300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
19782
39564
59347
79129
98911
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17364
34728
52092
69456
86820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.527
AC:
80107
AN:
152114
Hom.:
21911
Cov.:
34
AF XY:
0.525
AC XY:
39051
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.384
AC:
15922
AN:
41510
American (AMR)
AF:
0.611
AC:
9344
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.716
AC:
2483
AN:
3468
East Asian (EAS)
AF:
0.496
AC:
2554
AN:
5154
South Asian (SAS)
AF:
0.516
AC:
2492
AN:
4826
European-Finnish (FIN)
AF:
0.551
AC:
5832
AN:
10590
Middle Eastern (MID)
AF:
0.748
AC:
220
AN:
294
European-Non Finnish (NFE)
AF:
0.583
AC:
39598
AN:
67970
Other (OTH)
AF:
0.589
AC:
1242
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1954
3907
5861
7814
9768
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.578
Hom.:
44144
Bravo
AF:
0.526
Asia WGS
AF:
0.486
AC:
1691
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jun 07, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 20, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Leber congenital amaurosis 4 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Retinitis Pigmentosa, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa;C1858386:Leber congenital amaurosis 4 Benign:1
Aug 11, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.5
DANN
Benign
0.69
PhyloP100
-0.090
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000017
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12453262; hg19: chr17-6331836; COSMIC: COSV51506213; API